|
| Dominican Republic |
 |
|
| Comprehensive Indicator Report |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Adults and children living with HIV/AIDS
|
2005 |
66,000 |
330,000 |
38,600,000 |
UNAIDS, 2006 |
Adults (ages 15+) living with HIV/AIDS
|
2005 |
62,000 |
300,000 |
36,300,000 |
UNAIDS, 2006 |
Women (ages 15+) living with HIV/AIDS
|
2005 |
31,000 |
160,000 |
17,300,000 |
UNAIDS, 2006 |
Children (ages 0-14) living with HIV/AIDS
|
2005 |
3,600 |
22,000 |
2,300,000 |
UNAIDS, 2006 |
AIDS orphans currently living (ages 0-17) (I-1)
|
2005 |
nd |
nd |
15,200,000 |
UNAIDS, 2006 |
Adults and child AIDS deaths
|
2005 |
6,700 |
27,000 |
2,800,000 |
UNAIDS, 2006 |
Adults and children newly infected with HIV
|
2005 |
nd |
30,000 |
4,900,000 |
UNAIDS, 2005 |
| nd = No data | |
|
Adult (ages 15-49) HIV prevalence
(%) |
2005 |
1.1 |
1.6 |
1.0 |
UNAIDS, 2006 |
HIV prevalence, female sex workers, capital city (I-2)
(median %) |
2004-2005 |
3.6 |
nd |
nd |
UNAIDS, 2006 |
HIV prevalence, injecting drug users, capital city (I-2)
(median %) |
2004-2005 |
nd |
nd |
nd |
UNAIDS, 2006 |
HIV prevalence, young pregnant women (ages 15-24), capital city (I-2)
(median %) |
2003-2005 |
nd |
nd |
nd |
UNAIDS, 2006 |
HIV prevalence, men who have sex with men, capital city (I-2)
(median %) |
2004-2005 |
nd |
nd |
nd |
UNAIDS, 2006 |
| nd = No data | |
|
Had sex before age 15 (female, ages 15-24) (I-3)
(%) |
2003-2005 |
nd |
nd |
nd |
UNAIDS, 2006 |
Had sex before age 15 (male, ages 15-24) (I-3)
(%) |
2003-2005 |
nd |
nd |
nd |
UNAIDS, 2006 |
Reported higher-risk sex (female, ages 15-24) in the last year (I-4)
(%) |
2003-2005 |
nd |
nd |
nd |
UNAIDS, 2006 |
Reported higher-risk sex (male, ages 15-24) in the last year (I-4)
(%) |
2003-2005 |
nd |
nd |
nd |
UNAIDS, 2006 |
Used a condom the last time they had higher-risk sex, of those who had higher-risk
sex in the last year (female, ages 15-24) (I-5)
(%) |
2000-2005 |
nd |
nd |
nd |
UNAIDS, 2006 |
Used a condom the last time they had higher-risk sex, of those who had higher-risk
sex in the last year (male, ages 15-24) (I-5)
(%) |
2000-2005 |
nd |
nd |
nd |
UNAIDS, 2006 |
Displayed comprehensive HIV and AIDS knowledge (female, ages 15-24) (I-6)
(%) |
2003-2005 |
nd |
nd |
nd |
UNAIDS, 2006 |
Displayed comprehensive HIV and AIDS knowledge (male, ages 15-24) (I-6)
(%) |
2003-2005 |
nd |
nd |
nd |
UNAIDS, 2006 |
| nd = No data | |
|
Percent of adults receiving VCT in last year (I-7)
|
2003 |
1.2 |
0.3 |
nd |
WHO Health Services Coverage, 2004 |
Number of VCT clients per year (I-8)
|
2003 |
58,051 |
733,911 |
6,000,000 |
WHO Health Services Coverage, 2004 |
Number of VCT sites (I-8)
|
2003 |
85 |
5,063 |
nd |
WHO Health Services Coverage, 2004 |
Percent of pregnant women offered PMTCT services (I-9)
|
2003 |
37 |
34 |
8 |
WHO Health Services Coverage, 2004 |
Percent of HIV+ pregnant women receiving ARV prophylaxis (I-10)
|
2003-2005 |
nd |
nd |
nd |
UNAIDS, 2006 |
Number of sites offering PMTCT services (I-9)
|
2003 |
189 |
20,984 |
37,513 |
WHO Health Services Coverage, 2004 |
Estimated coverage of antiretroviral therapy (I-11)
(est. %) |
December 2005 |
17 |
68 |
20 |
WHO 3 by 5 Progress Report, 2006 |
Estimated number of people receiving antiretroviral therapy (I-12)
|
December 2005 |
2,500-3,000 |
315,000 |
1,330,000 |
WHO 3 by 5 Progress Report, 2006 |
Number of sites reported to provide antiretroviral therapy services (I-13)
|
September-December 2005 |
nd |
nd |
nd |
WHO 3 by 5 Progress Report, 2006 |
Coverage of cotrimoxazole prophylaxis for adults (I-14)
(est. %) |
2003 |
2 |
21 |
nd |
WHO Health Services Coverage, 2004 |
Number of adults receiving cotrimoxazole prophylaxis (I-15)
|
2003 |
300 |
29,794 |
190,000 |
WHO Health Services Coverage, 2004 |
Coverage of cotrimoxazole prophylaxis for children (I-16)
(est. %) |
2003 |
10 |
3 |
nd |
WHO Health Services Coverage, 2004 |
Number of children receiving cotrimoxazole prophylaxis (I-15)
|
2003 |
218 |
1,156 |
28,000 |
WHO Health Services Coverage, 2004 |
Coverage of isoniazid prophylaxis for adults (I-14)
(est. %) |
2003 |
2 |
11 |
nd |
WHO Health Services Coverage, 2004 |
Number of adults receiving isoniazid prophylaxis (I-15)
|
2003 |
300 |
15,077 |
36,000 |
WHO Health Services Coverage, 2004 |
Percentage of population living in areas with DOTS coverage (I-17)
|
2004 |
79 |
nd |
83 |
WHO TB Control Report, 2006 |
Number of TB cases registered for treatment under DOTS (I-18)
|
2003 |
1,883 |
nd |
1,711,585 |
WHO TB Control Report, 2006 |
| nd = No data | |
|
|
|
|
Life expectancy at birth (I-25)
(years) |
Various Years |
68 |
69 |
67 |
PRB Data Sheet, 2005 |
Infant (Ages 0-1) mortality rate (I-26)
(per 1,000 live births) |
2004 |
27 |
26 |
54 |
UNICEF, 2006 |
Under-five mortality rate (I-27)
(per 1,000 live births) |
2004 |
32 |
31 |
79 |
UNICEF, 2006 |
Maternal mortality ratio (I-28)
(per 100,000 live births) |
2000 |
150 |
nd |
nd |
UNFPA, 2005 |
Probability at birth of surviving to age 65, female (I-29)
(% of cohort) |
2000-2005 |
75.1 |
79.7 |
73.1 |
UNDP, 2005 |
Probability at birth of surviving to age 65, male (I-29)
(% of cohort) |
2000-2005 |
60.8 |
68.2 |
64.5 |
UNDP, 2005 |
| nd = No data | |
|
|
|
|
|
|
|
Gross national income (I-33)
(US$ per capita) |
2004 |
2,080 |
3,280 |
6,280 |
World Bank, 2005 |
Gross domestic product (I-34)
(US$, millions) |
2004 |
18,673 |
1,672,945 |
40,887,837 |
World Bank, 2005 |
| nd = No data | |
|
|
|
|
Health expenditure, private and public (I-37)
(US$ per capita) |
2002 |
295 |
nd |
nd |
UNDP, 2005 |
Physicians per 100,000 people (I-38)
|
1990-2004 |
188 |
nd |
nd |
UNDP, 2005 |
Births attended by skilled health staff (I-39)
(%) |
1995-2003 |
99 |
82 |
62 |
UNDP, 2005 |
Malaria cases per 100,000 people (I-40)
|
2000 |
6 |
nd |
nd |
UNDP, 2005 |
Prevalence of child (ages 0-5) malnutrition (I-41)
(%) |
1996-2004 |
5 |
7 |
26 |
UNICEF, 2006 |
TB treatment success rate, new smear-positive cases-DOTS (I-42)
(% of cases) |
2003 |
81 |
nd |
82 |
WHO TB Control Report, 2006 |
| nd = No data | |
|
|
|
|
Child (ages 0-1) immunization rate, measles
(%) |
2004 |
79 |
92 |
76 |
UNICEF, 2006 |
Child (ages 0-1) immunization rate, DPT (I-44)
(%) |
2004 |
71 |
91 |
78 |
UNICEF, 2006 |
| nd = No data | |
|
|
|
|
|
|
|
|
| I-1. |
Estimated number of children ages 0 to 17 who have lost one or both parents
to AIDS. |
| I-2. |
See the UNAIDS report to find the year of data collection for individual
countries. |
| I-3. |
Data collection varies between 2003 and 2005. |
| I-4. |
Proportion of 15-24-year-old respondents who had sex with a non-marital,
non-cohabiting partner in the last 12 months, of all respondents reporting sexual activity in the last 12 months. Data collection
varies between 2003 and 2005. |
| I-5. |
Percentage of 15-24-year-old respondents who say they used a condom the last
time they had sex with a non-marital, non-cohabiting partner, of those who have had sex with such a partner in the last 12
months. Data collection varies between 2000 and 2005. |
| I-6. |
Percentage of 15-24-year-old respondents who could correctly answer 5 questions
regarding HIV transmission. Data collection varies between 2003 and 2005. |
| I-7. |
Voluntary counseling and testing refers to services providing pre-test counseling,
testing for HIV infection, and post-test counseling for anyone wanting to know their HIV status. It does not include testing
done on hospital patients for medical purposes. Although the entire adult population may not be in need of VCT, statistics
from VCT programs indicate that clients represent a mix of risk behaviors. |
| I-8. |
Voluntary counseling and testing refers to services providing pre-test counseling,
testing for HIV infection, and post-test counseling for anyone wanting to know their HIV status. It does not include testing
done on hospital patients for medical purposes. |
| I-9. |
Prevention of mother-to-child transmission refers to services that provide
voluntary counseling and testing for pregnant women and provide prevention services to those who are HIV positive. Prevention
services should include treatment with zidovudine, nevirapine or other antiretroviral drugs and may also include breastfeeding
counseling and supplemental feeding. |
| I-10. |
Percentage of HIV-infected pregnant women receiving a complete course of
antiretroviral prophylaxis to reduce the risk of mother-to-child transmission, according to the nationally approved treatment
protocol or WHO/UNAIDS standards, in the last 12 months. Data collection varies between 2003 and 2005. |
| I-11. |
The level of coverage is a measure of the number of people receiving antiretroviral
therapy by December 2005 divided by the total number of people estimated to need treatment. The total number of people needing
antiretroviral therapy is calculated by adding the number of people who need to start antiretroviral therapy to the number
of people who were receiving treatment in the previous year and survived into the current year. |
| I-12. |
Antiretroviral therapy refers to the treatment of HIV-positive adults or
children with a combination of at least three antiretroviral drugs. An increasing number of countries report the number of
children younger than 15 years of age receiving antiretroviral therapy, and they have been included in this table. |
| I-13. |
Antiretroviral therapy refers to the treatment of HIV-positive adults or
children with a combination of at least three antiretroviral drugs. The reported sites reflect mainly the situation in the
public sector. Some countries separately report private-sector data or include the private-sector figures in the overall numbers
(see data notes). |
| I-14. |
Cotrimoxazole or isoniazid are provided to people who are identified as being
HIV positive as prophylaxis for opportunistic infections. The number needing prophylaxis includes the adults with HIV who
are within 2 years of dying from AIDS without antiretroviral therapy. This number is estimated to be twice the number of deaths
from AIDS in 2003. |
| I-15. |
Cotrimoxazole or isoniazid are provided to people who are identified as being
HIV positive as prophylaxis for opportunistic infections. |
| I-16. |
Cotrimoxazole or isoniazid are provided to people who are identified as being
HIV positive as prophylaxis for opportunistic infections. It is assumed that all children who are HIV positive need prophylaxis. |
| I-17. |
The percentage of the national population living in areas where health services
have adopted DOTS (Directly Observed Treatment, Short-course). |
| I-18. |
The number of new smear-positive cases registered for treatment under DOTS
(Directly Observed Treatment, Short-course) in 2003. |
| I-19. |
Measures average achievements in three basic dimensions of human development:
life expectancy at birth; adult literacy and school enrollment; and GDP per capita. |
| I-20. |
Measures the extent to which the distribution of income (or consumption)
among individuals or households within a country deviates from a perfectly equal distribution. A value of 0 represents perfect
equality, a value of 100 perfect inequality. Because the underlying household surveys differ in method and in the type of
data collected and refer to different years, the distribution data are not strictly comparable across countries. |
| I-21. |
Reflects inequalities between men and women using unweighted average of three
component indices: life expectancy, education index, and income index. |
| I-22. |
Reflects inequalities between men and women using unweighted average of three
component indices: life expectancy, education index, and income index. Values range from 0 (lowest gender equality) to 1 (highest
gender equality). |
| I-23. |
Focusing on women's opportunities rather than their capabilities, GEM captures
gender inequality in three key areas: (1) political participation and decisionmaking power, as measured by women's and men's
percentage shares of parliamentary seats; (2) economic participation and decisionmaking power, as measured by (a) women's
and men's percentage shares of positions as legislators, senior officials, and managers and (b) women's and men's percentage
shares of professional and technical positions; and (3) power over economic resources, as measured by women's and men's estimated
earned income. |
| I-24. |
Focusing on women's opportunities rather than their capabilities, GEM captures
gender inequality in three key areas: (1) political participation and decisionmaking power, as measured by women's and men's
percentage shares of parliamentary seats; (2) economic participation and decisionmaking power, as measured by (a) women's
and men's percentage shares of positions as legislators, senior officials, and managers and (b) women's and men's percentage
shares of professional and technical positions; and (3) power over economic resources, as measured by women's and men's estimated
earned income. Values range from 0 (lowest gender equality) to 1 (highest gender equality). |
| I-25. |
The average number of years a newborn infant can expect to live under current
mortality levels. For countries with complete registration of births and deaths, rates are those most recently reported. For
more developed countries, nearly all vital rates refer to 2003 or 2004, and for less developed countries, to some point in
the late 1990s or early 2000s. |
| I-26. |
Probability of dying between birth and exactly one year of age, expressed
per 1,000 live births. |
| I-27. |
Probability of dying between birth and exactly five years of age, expressed
per 1,000 live births. |
| I-28. |
Number of deaths to women per 100,000 live births that result from conditions
related to pregnancy, delivery, and related complications. These are consensus estimates of WHO, UNICEF, and UNFPA. |
| I-29. |
The probability of a newborn infant surviving to age 65 if subject to prevailing
patterns of age specific mortality rates. Data refer to estimates for the period specified. |
| I-30. |
Based upon reasonable assumptions on the future course of fertility, mortality,
and migration using official country projections, series issued by the U.N. or the U.S. Census Bureau, or PRB projections. |
| I-31. |
The birth rate minus the death rate, implying the annual rate of population
growth (expressed as a percentage) without regard for migration. For countries with complete registration of births and deaths,
rates are those most recently reported. For more developed countries, nearly all vital rates refer to 2003 or 2004, and for
less developed countries, to some point in the late 1990s or early 2000s. |
| I-32. |
Percentage of total population living in areas termed "urban" by that country.
Typically, the population living in towns of 2,000 or more or in national and provincial capitals is classified as "urban." |
| I-33. |
May be thought of as average income. GNI per capita (formerly GNP per capita)
= gross national income, converted to U.S. dollars using the World Bank Atlas method (see below), divided by the midyear population.
Gross national income = sum of value added by all resident producers plus any product taxes (less subsidies) not included
in the valuation of output plus net receipts of primary income (compensation of employees and property income) from abroad.
GNI, calculated in national currency, is usually converted to U.S. dollars at official exchange rates for comparisons across
economies, although an alternative rate is used when the official exchange rate is judged to diverge by an exceptionally large
margin from the rate actually applied in international transactions. To smooth fluctuations in prices and exchange rates,
the World Bank uses the Atlas method, which applies a conversion factor that averages the exchange rate for a given year and
the two preceding years, adjusted for differences in rates of inflation between the country and the G-5 countries (France,
Germany, Japan, U.K., and U.S.). |
| I-34. |
GDP is the sum of gross value added by all resident producers in the economy
plus any product taxes and minus any subsidies not included in the value of the products. It is calculated without making
deductions for depreciation of fabricated assets or for depletion and degradation of natural resources. Data are in current
U.S. dollars. Dollar figures for GDP are converted from domestic currencies using single year official exchange rates. For
a few countries where the official exchange rate does not reflect the rate effectively applied to actual foreign exchange
transactions, an alternative conversion factor is used. |
| I-35. |
The percentage of the population living below the poverty line deemed appropriate
for a country by its authorities. National estimates are based on population-weighted subgroup estimates from household surveys.
Data refer to the most recent year available during the period specified. |
| I-36. |
The percentage of the population living below $1 a day--at 1985 international
prices (equivalent to $1.08 at 1993 international prices), adjusted for purchasing power parity. Data refer to the most recent
year available during the period specified. |
| I-37. |
The sum of public and private expenditure (in US$ adjusted for purchasing
power parity), divided by the population. Health expenditure includes the provision of health services (preventive and curative),
family planning activities, nutrition activities and emergency aid designated for health, but excludes the provision of water
and sanitation. |
| I-38. |
Includes graduates of a faculty or school of medicine who are working in
any medical field (including teaching, research and practice). Data refer to the most recent year available during the period
specified. |
| I-39. |
The percentage of deliveries attended by personnel (including doctors, nurses
and midwives) trained to give the necessary care, supervision and advice to women during pregnancy, labour and the postpartum
period, to conduct deliveries on their own and to care for newborns. Data refer to the most recent year available during the
period specified. |
| I-40. |
The total number of malaria cases reported to the World Health Organization
by countries in which malaria is endemic. Many countries report only laboratory-confirmed cases, but many in Sub-Saharan Africa
report clinically diagnosed cases as well. Data refer to malaria cases reported to the World Health Organization (WHO) and
may represent only a fraction of the true number in a country. |
| I-41. |
Percentage of children under five whose weight for age is below minus two
standard deviations from median weight for age of reference population. Data refer to the most recent year available during
the period specified. |
| I-42. |
Percentage of new, registered smear-positive (infectious) cases that were
cured or in which a full-course treatment was completed. TB case notifications represent only a fraction of the true number
of cases arising in a country because of incomplete coverage by health services, inaccurate diagnosis, or deficient recording
and reporting. |
| I-43. |
The estimated percentage of the population for whom a minimum of 20 of the
most essential drugs-those that satisfy the health care needs of the majority of the population-are continuously and affordably
available at public or private health facilities or drug outlets within one hour's travel from home. The data on access to
essential drugs are based on statistical estimates received from World Health Organization (WHO) country and regional offices
and regional advisers and through the World Drug Situation Survey carried out in 1998-99. These estimates represent the best
information available to the WHO Department of Essential Drugs and Medicines Policy to date and are currently being validated
by WHO member states. The department assigns the estimates to four groupings: very low access (0-49%), low access (50-79%),
medium access (80-94%) and good access (95-100%). These groupings, used here in presenting the data, are often employed by
the WHO in interpreting the data, as the actual estimates may suggest a higher level of accuracy than the data afford. |
| I-44. |
Percentage of infants that received three doses of diphtheria, pertussis
(whooping cough) and tetanus vaccine. |
| I-45. |
The number of children a woman would have during her reproductive years if
she bore children at the rate estimated for different age groups in the specified time period. |
| I-46. |
Burden of fertility on young women. As it is an annual level summed over
all women in the age cohort, it does not reflect fully the level of fertility for women during their youth. Does not indicate
the full dimensions of teen pregnancy as only live births are included in the numerator. Stillbirths and spontaneous or induced
abortions are not reflected. |
| I-47. |
The percentage of all women who give birth before their 18th birthday. In
countries where only ever-married women are surveyed, data on out-of-wedlock births is not available. |
| I-48. |
The number of children enrolled in a level (primary or secondary), regardless
of age, divided by the population of the age group that officially corresponds to the same level. This is a standard indicator
of the level of participation in education. The goal is to be as close to 100% as possible. In countries with gross enrollment
ratios of less than 100%, there are not enough schools or slots for students, and children may not be taking the slots that
are available because they are kept out of school. In countries with gross enrollment ratios over 100%, there is much under-
and/or overaged enrollment, meaning that many students are above or below the official age for the grade; this may be the
result of having to repeat grades or entering school late because of work and/or inability to afford school fees. Data refer
to the most recent year available during the period specified. | | |
|
